Intraoperative corneal thickness measurements during corneal collagen cross-linking with hypoosmolar riboflavin solution in thin corneas

Cornea

Volumn 31, Issue 5, 2012, Pages 486-490

  Kaya, Vedat ^a   Utine, Canan Asli ^b   Ylmaz, Ömer Faruk ^a  

^a Beyoglu Eye Research and Training Hospital   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

collagen cross linking; corneal thickness; thin cornea

Indexed keywords

COLLAGEN; DEXTRAN; HYPOTONIC SOLUTION; ISOTONIC SOLUTION; RIBOFLAVIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CORNEA; CORNEA THICKNESS; CROSS LINKING; DEBRIDEMENT; HUMAN; KERATOCONUS; OSMOLARITY; PEROPERATIVE CARE; PRIORITY JOURNAL;

ADULT; BODY WEIGHTS AND MEASURES; COLLAGEN; CORNEA; CORNEAL STROMA; CROSS-LINKING REAGENTS; DEXTRANS; DILATATION, PATHOLOGIC; HUMANS; HYPOTONIC SOLUTIONS; ISOTONIC SOLUTIONS; KERATOCONUS; MONITORING, INTRAOPERATIVE; OSMOLAR CONCENTRATION; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 84860006045     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31821e4286     Document Type: Article

References (25)

1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627. (Pubitemid 36457967)
2. Hafezi F, Kanellopoulos J, Wiltfang R, et al. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33:2035-2040. (Pubitemid 350167516)
3. Caporossi A, Mazzotta C, Baiocchi S, et al. Long-term results of riboflavin ultraviolet A corneal collagen cross-linking for keratoconus in Italy: The Siena Eye Cross Study. Am J Ophthalmol. 2010;149:585-593.
4. Vinciguerra P, Albé E, Trazza S, et al. Intraoperative and postoperative effects of corneal collagen cross-linking on progressive keratoconus. Arch Ophthalmol. 2009;127:1258-1265.
5. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin crosslinking of the cornea. Cornea. 2007;26:385-389.
6. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356-360. (Pubitemid 44215044)
7. Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. 2009;35:540-546.
8. Kymionis GD, Diakonis VF, Coskunseven E, et al. Customized pachymetric guided epithelial debridement for corneal collagen cross linking. BMC Ophthalmol. 2009;9:10.
9. Hafezi F, Mrochen M, Iseli HP, et al. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg. 2009;35:621-624.
10. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97-103. (Pubitemid 28070342)
11. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin/ultraviolet induced cross-linking. J Cataract Refract Surg. 2003;23:1780-1785. (Pubitemid 37210617)
12. Spoerl E, Wollensak G, Seiler T. Increased resistance of cross-linked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40. (Pubitemid 39389439)
13. Wollensak G, Spö rl E, Reber F, et al. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res. 2003;35: 324-328. (Pubitemid 38032509)
14. Goldich Y, Marcovich AL, Barkana Y, et al. Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus. Cornea. 2010;29:409-411.
15. Spö rl E, Raiskup-Wolf F, Pillunat LE. Biophysikalische Grundlagen der Kollagenvernetzung Biophysical principles of collagen cross-linking [in German]. Klin Monatsbl Augenheilkd. 2008;225:131-137.
16. Wollensak G, Aurich H,Wirbelauer C, et al. Significance of the riboflavin film in corneal collagen crosslinking. J Cataract Refract Surg. 2010;36: 114-120.
17. Kymionis GD, Kounis GA, Portaliou DM, et al. Intraoperative pachymetric measurements during corneal collagen cross-linking with riboflavin and ultraviolet A irradiation. Ophthalmology. 2009;116: 2336-2339.
18. Esquenazi S, He J, Li N, et al. Immunofluorescence of rabbit corneas after collagen cross-linking treatment with riboflavin and ultraviolet A. Cornea. 2010;29:412-417.
19. Wollensak G. Histological changes in human cornea after crosslinking with riboflavin and ultraviolet A. Acta Ophthalmol. 2009;88: e17-e18.
20. Wollensak G, Spoerl E,Wilsch M, et al. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea. 2004;23: 43-49. (Pubitemid 38031874)
21. Mazzotta C, Traversi C, Baiocchi S, et al. Conservative treatment of keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: qualitative investigation. Eur J Ophthalmol. 2006;16:530-535.
22. Hamaoui M, Tahi H, Chapon P, et al. Corneal preparation of eye bank eyes for experimental surgery. Cornea. 2001;20:317-320. (Pubitemid 32239273)
23. Mü ller LJ, Pels E, Vrensen GF. The effects of organ-culture on the density of keratocytes and collagen fibers in human corneas. Cornea. 2001;20: 86-95. (Pubitemid 32038162)
24. Ahearne M, Yang Y, Then KY, et al. Non-destructive mechanical characterization of UVA/riboflavin crosslinked collagen hydrogels. Br J Ophthalmol. 2008;92:268-271. (Pubitemid 351224109)
25. Srinivas SP. Dynamic regulation of barrier integrity of the corneal endothelium. Optom Vis Sci. 2010;87:E239-E254.